Mark Augusti - ConforMIS President CEO, Director
| CFMSDelisted Stock | USD 2.23 0.01 0.45% |
CEO
Mr. Mark A. Augusti is President, Chief Executive Officer, Director of the Company, since November 2016. Mr. Augusti was Integra LifeSciences Corporationrationrations corporate vice president, and president of Orthopedics and Tissue Technologies. Mr. Augusti was responsible for the management of the Orthopedics and Tissue Technologies global division, which includes extremity implants, tissue products, and the Private Label business. His responsibilities included U.S. commercial leadership, global portfolio management, evaluation of corporate development opportunities and overall strategic direction. Prior to joining Integra in 2014, Mr. Augusti served as chief executive officer at Bioventus LLC from May 2012 to August 2013, and was a member of Bioventus board of directors during the same period. Prior to that, Mr. Augusti spent nine years with Smith Nephew from April 2003 to April 2012 in a series of leadership roles, including President of Smith Nephews Biologic Division, where he was appointed to lead Smith Nephews new biologics initiative. He also served as Smith Nephews president of the Orthopaedic Trauma Clinical Therapies global business and senior vice president and general manager of the Trauma business. From 1987 to 2000, he spent 13 years at GE Medical Systems, where he held various sales, marketing and strategic management roles, both in the U.S. and internationally since 2016.
| Age | 57 |
| Tenure | 8 years |
| Professional Marks | MBA |
| Phone | 781 345 9001 |
| Web | https://www.conformis.com |
ConforMIS Management Efficiency
The company has return on total asset (ROA) of (0.2732) % which means that it has lost $0.2732 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7871) %, meaning that it created substantial loss on money invested by shareholders. ConforMIS's management efficiency ratios could be used to measure how well ConforMIS manages its routine affairs as well as how well it operates its assets and liabilities.ConforMIS currently holds 27.5 M in liabilities with Debt to Equity (D/E) ratio of 0.38, which is about average as compared to similar companies. ConforMIS has a current ratio of 5.6, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about ConforMIS's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Found 14 records | CEO Age | ||
| Nadim Yared | CVRx Inc | 56 | |
| Nestor Jaramillo | Nuwellis | 67 | |
| Jeffrey Frelick | Bone Biologics Corp | 58 | |
| Maria Sainz | Hyperfine | 58 | |
| Kevin Hykes | CVRx Inc | 58 | |
| Jack Phillips | Accelerate Diagnostics | 58 | |
| Robert Spignesi | Rapid Micro Biosystems | 55 | |
| Andrew Simpson | Heart Test Laboratories | 55 | |
| Joseph Woody | Avanos Medical | 58 | |
| Massimo Calafiore | Orthofix Medical | 52 | |
| Joel Becker | Neuropace | 56 | |
| Karen Zaderej | Axogen Inc | 62 | |
| Michael CPA | Avanos Medical | 51 | |
| Mark Throdahl | Orthopediatrics Corp | 73 | |
Management Performance
| Return On Equity | -0.79 | |||
| Return On Asset | -0.27 |
ConforMIS Leadership Team
Elected by the shareholders, the ConforMIS's board of directors comprises two types of representatives: ConforMIS inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ConforMIS. The board's role is to monitor ConforMIS's management team and ensure that shareholders' interests are well served. ConforMIS's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ConforMIS's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Robert Howe, CFO Treasurer | ||
| Michael Fillion, Chief Officer | ||
| Erin Henry, Co Controller | ||
| MPH JD, Chief Sec | ||
| Farzin Khaghani, VP Marketing | ||
| Christine Desrochers, Co Controller | ||
| Mark Augusti, President CEO, Director | ||
| Allison Baker, Director HR | ||
| Eric Rickenbach, VP Sales | ||
| Terrance Wong, VP Regulatory |
ConforMIS Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is ConforMIS a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.79 | |||
| Return On Asset | -0.27 | |||
| Profit Margin | (0.73) % | |||
| Operating Margin | (0.71) % | |||
| Current Valuation | 18.21 M | |||
| Shares Outstanding | 7.88 M | |||
| Shares Owned By Insiders | 6.28 % | |||
| Shares Owned By Institutions | 22.50 % | |||
| Number Of Shares Shorted | 83.58 K | |||
| Price To Earning | 5.96 X |
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Consideration for investing in ConforMIS Stock
If you are still planning to invest in ConforMIS check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ConforMIS's history and understand the potential risks before investing.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |